Profound Medical Corp Share Price Toronto S.E.
Equities
PRN
CA74319B1067
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- CAD | - |
15/05 | Transcript : Profound Medical Corp. - Shareholder/Analyst Call | |
14/05 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
Sales 2024 * | 15.5M 11.38M 948M | Sales 2025 * | 41.51M 30.48M 2.54B | Capitalization | 273M 201M 16.72B |
---|---|---|---|---|---|
Net income 2024 * | -40M -29.37M -2.45B | Net income 2025 * | -31M -22.76M -1.9B | EV / Sales 2024 * | 17.6 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 6.58 x |
P/E ratio 2024 * |
-7.01
x | P/E ratio 2025 * |
-7.58
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.29% |
Latest transcript on Profound Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 69 | 04/15/04 |
Rashed Dewan
DFI | Director of Finance/CFO | 56 | 01/15/01 |
Mathieu Burtnyk
COO | Chief Operating Officer | 42 | 07/11/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Rosenthal
BRD | Director/Board Member | 77 | 14/18/14 |
Director/Board Member | 67 | 14/18/14 | |
Cynthia Lavoie
BRD | Director/Board Member | - | 03/21/03 |
1st Jan change | Capi. | |
---|---|---|
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- PRN Stock
- PRN Stock